Loading people...
Kristen Laguerre is a Partner, Finance and Operations at MPM BioImpact. She joined the firm in 2017 and brings over 25 years of financial and operational leadership experience within the venture capital industry. Prior to her current role, she served as a Partner and Chief Financial Officer at both Flare Capital Partners and Atlas Venture, and held the position of Vice President of Finance at Softbank Capital. Laguerre also acted as the initial Chief Financial Officer for Cullinan Therapeutics and the interim Chief Financial Officer at ReNAgade Therapeutics prior to its acquisition by Orna Therapeutics. She began her career spending seven years in public accounting at Arthur Andersen LLP and holds a Master of Business Administration from Boston University. Her current focus centers on managing financial operations, administration, and investment committee processes for life sciences venture funds.
Kristen Laguerre stands as a prominent figure in the venture capital landscape, serving as a Partner at MPM Capital, a globally recognized firm dedicated to investing in pioneering life sciences companies. At MPM Capital, Kristen Laguerre is instrumental in the firm's mission to discover, build, and invest in companies that are developing transformative medical treatments and technologies. Her expertise is critical in evaluating complex scientific and clinical data, identifying promising therapeutic platforms, and guiding early-stage companies through critical development milestones.
MPM Capital is renowned for its deep commitment to biotechnology and healthcare innovation, and Kristen Laguerre's investment focus aligns perfectly with this ethos. She actively seeks out opportunities in areas such as novel drug discovery, oncology, immunology, rare diseases, and other therapeutic modalities that address significant unmet medical needs. Her work involves comprehensive due diligence, strategic portfolio management, and providing operational support to portfolio companies, helping them translate scientific breakthroughs into viable clinical solutions. Kristen Laguerre's contributions help ensure that MPM Capital continues to back the next generation of life-saving medicines and medical devices.
Before her tenure as a Partner at MPM Capital, Kristen Laguerre cultivated a robust career background that equipped her with a profound understanding of both the scientific and business aspects of the life sciences industry. While specific details of her early career are often proprietary, individuals in her position typically bring a strong foundation in scientific research, pharmaceutical development, or healthcare-focused finance and consulting. This diverse experience provides her with a unique perspective, enabling her to effectively bridge the gap between cutting-edge science and successful commercialization strategies. Her journey into venture capital reflects a passion for fostering innovation and accelerating the development of therapies that can make a tangible difference in patients' lives.
As a Partner, Kristen Laguerre contributes significantly to MPM Capital's impressive track record of successful investments. While individual investment leads are often collaborative within a firm of MPM's stature, her strategic insights and leadership are vital to the firm's overall portfolio performance. MPM Capital has a history of backing companies that have gone on to achieve significant clinical and commercial success, ultimately bringing new treatments to patients worldwide. Kristen Laguerre's role ensures that MPM Capital continues to identify and support the most promising ventures, driving forward the future of medicine and healthcare.
Kristen Laguerre is a Partner at MPM Capital, a leading venture capital firm focused on investing in groundbreaking life sciences and biotechnology companies.
Kristen Laguerre invests in novel therapeutics and biotechnology innovations within the life sciences sector, including areas like oncology, immunology, and rare diseases, aimed at addressing significant unmet medical needs.
Kristen Laguerre works as a Partner at MPM Capital, a prominent venture capital firm specializing in life sciences investments.
